ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 108 filers reported holding ARATANA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 93.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,632,000 | -21.0% | 923,722 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $8,391,000 | +52.7% | 896,521 | +3.1% | 0.00% | 0.0% |
| Q2 2016 | $5,495,000 | +30.9% | 869,516 | +14.4% | 0.00% | 0.0% |
| Q1 2016 | $4,197,000 | +1.0% | 760,273 | +2.1% | 0.00% | 0.0% |
| Q4 2015 | $4,157,000 | -35.2% | 744,986 | -1.7% | 0.00% | 0.0% |
| Q3 2015 | $6,413,000 | -18.3% | 758,003 | +46.1% | 0.00% | 0.0% |
| Q2 2015 | $7,845,000 | -2.4% | 518,824 | +3.4% | 0.00% | 0.0% |
| Q1 2015 | $8,037,000 | +24.8% | 502,006 | +38.9% | 0.00% | 0.0% |
| Q4 2014 | $6,439,000 | +125.0% | 361,330 | +26.7% | 0.00% | – |
| Q3 2014 | $2,862,000 | -32.7% | 285,096 | +4.7% | 0.00% | -100.0% |
| Q2 2014 | $4,250,000 | -27.4% | 272,265 | -13.6% | 0.00% | 0.0% |
| Q1 2014 | $5,851,000 | +204.6% | 315,250 | +213.4% | 0.00% | – |
| Q4 2013 | $1,921,000 | +56.9% | 100,578 | +34.3% | 0.00% | – |
| Q3 2013 | $1,224,000 | – | 74,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |